Todd Zavodnick - Zeltiq Aesthetics President International

President

Mr. Todd E. Zavodnick was appointed as President International, Global Sales and Physician Training of the Company effective January 17, 2017. He was President, International of the Company., since February 2016. Prior to joining ZELTIQ, Mr. Zavodnick was the President General Manager of Galderma North America, where he was responsible for all North America operations within the Pharmaceutical, Consumer, and Aesthetic Corrective businesses. He also previously served as Galdermas Vice President, General Manager Aesthetic Corrective USA, from May 2014 to January 2015, during which time he was responsible for Galdermas Aesthetic Corrective operations in the United States. Todd also served as Senior Regional Director for Galderma European and Latin America Operations, from May 2012 to January 2015, during which time he was responsible for all operations within Europe, Middle East, Africa, and Latin America for Galderma regarding all business units of Pharmaceutical, Consumer, and Aesthetic and Corrective Lines. Prior to joining Galderma, Mr. Zavodnick served as President, China and Mongolia for Alcon, a Novartis company, from April 2009 to July 2012, at which he oversaw operations for Alcon China and Mongolia focusing on the areas of medical devices, pharmaceuticals and consumer eye care. In his career, Mr. Zavodnick has spent time leading organizations in Asia, Europe, the Middle East, Africa, and Latin America for Alcon Laboratories and Galderma Laboratories. He began his career as a Registered Pharmacist. In addition Mr. Zavodnick serves on the Board of Directors for the Children Skin Disease Foundation whose mission is to care for children with severe life threatening skin diseases since 2017.
Tenure 7 years
Professional MarksMBA
Phone925 474-2500
Webwww.coolsculpting.com
Zavodnick earned a BS degree in Pharmacy from Rutgers University and an M.B.A. from the University of Texas at Dallas.

Zeltiq Aesthetics Management Efficiency

Zeltiq Aesthetics' management efficiency ratios could be used to measure how well Zeltiq Aesthetics manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 382 K in liabilities with Debt to Equity (D/E) ratio of 0.44, which is about average as compared to similar companies. Zeltiq Aesthetics has a current ratio of 1.97, which is within standard range for the sector. Debt can assist Zeltiq Aesthetics until it has trouble settling it off, either with new capital or with free cash flow. So, Zeltiq Aesthetics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Zeltiq Aesthetics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Zeltiq to invest in growth at high rates of return. When we think about Zeltiq Aesthetics' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

PRESIDENT Age

Emelie TirreMonster Beverage Corp
54
Guy CarlingMonster Beverage Corp
47
ZELTIQ Aesthetics, Inc., a medical technology company, engages in developing and commercializing noninvasive solutions for the selective reduction of fat. Zeltiq Aesthetics (ZLTQ) is traded on NASDAQ Exchange in USA and employs 663 people.

Management Performance

Zeltiq Aesthetics Leadership Team

Elected by the shareholders, the Zeltiq Aesthetics' board of directors comprises two types of representatives: Zeltiq Aesthetics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zeltiq. The board's role is to monitor Zeltiq Aesthetics' management team and ensure that shareholders' interests are well served. Zeltiq Aesthetics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zeltiq Aesthetics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Taylor Harris, CFO, Senior Vice President
Keith Grossman, Independent Director
Brent Hauser, President - North America
Kevin OBoyle, Independent Director
Mark Foley, CEO and President and Director
Leonard DeBenedictis, CTO
Patrick Williams, CFO, Principal Accounting Officer and Sr. VP
Carl Lamm, VP of Operations
Keith Sullivan, Chief Commercial Officer and President of North America
David Endicott, Director
Sergio GarciaRodriguez, Senior Vice President General Counsel and Corporate Secretary
Brad Hauser, Vice President - Research and Development
Danika Harrison, Vice President - Global Marketing
Mary Fisher, Director
Andrew Schiff, Independent Director
Bryan Roberts, Independent Director
Todd Zavodnick, President International

Zeltiq Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zeltiq Aesthetics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zeltiq Aesthetics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zeltiq Aesthetics' short interest history, or implied volatility extrapolated from Zeltiq Aesthetics options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in Zeltiq Stock

If you are still planning to invest in Zeltiq Aesthetics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zeltiq Aesthetics' history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk